These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2237991)

  • 1. Platelet-activating factor. A putative mediator in central nervous system injury?
    Feuerstein G; Yue TL; Lysko PG
    Stroke; 1990 Nov; 21(11 Suppl):III90-4. PubMed ID: 2237991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-activating factor: a putative neuromodulator and mediator in the pathophysiology of brain injury.
    Yue TL; Feuerstein GZ
    Crit Rev Neurobiol; 1994; 8(1-2):11-24. PubMed ID: 7907280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of signal transduction in rat synaptoneurosomes by platelet activating factor.
    Domańska-Janik K; Zabłocka B
    Mol Chem Neuropathol; 1995 May; 25(1):51-67. PubMed ID: 7546018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-activating factor in stroke and brain injury.
    Lindsberg PJ; Hallenbeck JM; Feuerstein G
    Ann Neurol; 1991 Aug; 30(2):117-29. PubMed ID: 1897906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arachidonic acid metabolism and cerebral blood flow in the normal, ischemic, and reperfused gerbil brain. Inhibition of ischemia-reperfusion-induced cerebral injury by a platelet-activating factor antagonist (BN 52021).
    Panetta T; Marcheselli VL; Braquet P; Bazan NG
    Ann N Y Acad Sci; 1989; 559():340-51. PubMed ID: 2774404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginkgolides and platelet-activating factor binding sites.
    Hosford DJ; Domingo MT; Chabrier PE; Braquet P
    Methods Enzymol; 1990; 187():433-46. PubMed ID: 2172741
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet-activating factor antagonists limit glycine changes and behavioral deficits after brain trauma.
    Faden AI; Tzendzalian PA
    Am J Physiol; 1992 Oct; 263(4 Pt 2):R909-14. PubMed ID: 1415805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous platelet activating factor does not modulate blood flow and metabolism in normal rat brain.
    Kochanek PM; Melick JA; Schoettle RJ; Magargee MJ; Evans RW; Nemoto EM
    Stroke; 1990 Mar; 21(3):459-62. PubMed ID: 2309270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor antagonism enhances the liver's recovery from warm ischemia in situ.
    Minor T; Isselhard W
    J Hepatol; 1993 Jul; 18(3):365-8. PubMed ID: 8228131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a platelet activating factor antagonist (BN 52021) on neurologic outcome and histopathology in a canine model of complete cerebral ischemia.
    Hofer RE; Christopherson TJ; Scheithauer BW; Milde JH; Lanier WL
    Anesthesiology; 1993 Aug; 79(2):347-53. PubMed ID: 8342844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renal diseases and platelet activating factor].
    Pirotzky E; Colliez P; Guilmard C; Braquet P
    Pediatrie; 1989; 44(3):163-7. PubMed ID: 2740184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor antagonists reduce excitotoxic damage in cultured neurons from embryonic chick telencephalon and protect the rat hippocampus and neocortex from ischemic injury in vivo.
    Prehn JH; Krieglstein J
    J Neurosci Res; 1993 Feb; 34(2):179-88. PubMed ID: 8095559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-activating factor antagonist BN52021 improves survival in normothermic liver ischemia in rats.
    Borobia FG; Figueras J; Escriba JM; Farran L; Rafecas A; Fabregat J; Torras J; Jaurrieta E
    Transplant Proc; 1993 Aug; 25(4):2543-4. PubMed ID: 8356661
    [No Abstract]   [Full Text] [Related]  

  • 14. [Platelet-activating factor (PAF) antagonists].
    Terasawa M
    Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):379-87. PubMed ID: 1850862
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of a platelet activating factor antagonist (BN 52021) on free fatty acids, diacylglycerols, polyphosphoinositides and blood flow in the gerbil brain: inhibition of ischemia-reperfusion induced cerebral injury.
    Panetta T; Marcheselli VL; Braquet P; Spinnewyn B; Bazan NG
    Biochem Biophys Res Commun; 1987 Dec; 149(2):580-7. PubMed ID: 2827647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet activating factor antagonists do not alter normal cerebral blood flow or cerebral oxygen consumption.
    Kochanek PM; Melick JA; Schoettle RJ; Magargee MJ; Evans RW; Nemoto EM
    Adv Exp Med Biol; 1990; 277():345-51. PubMed ID: 2096640
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of preservation/reperfusion injury by platelet-activating factor antagonism in the rat liver graft.
    Minor T; Yamaguchi T; Isselhard W
    Transplant Proc; 1995 Feb; 27(1):522-3. PubMed ID: 7879086
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet-activating factor--key mediator in neuroinjury?
    Frerichs KU; Feuerstein GZ
    Cerebrovasc Brain Metab Rev; 1990; 2(2):148-60. PubMed ID: 2201347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The alkyl-ether phospholipid platelet-activating factor is a stimulator of the hypothalamic-pituitary-adrenal axis in the rat.
    Bernardini R; Calogero AE; Ehrlich YH; Brucke T; Chrousos GP; Gold PW
    Endocrinology; 1989 Aug; 125(2):1067-73. PubMed ID: 2546734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet activating factor antagonists interact with GABAA receptors.
    Miller LG; Bazan NG; Roy RB; Clostre F; Gaver A; Braquet P
    Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):253-6. PubMed ID: 1667341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.